Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

  1. Coleman, R.L.
  2. Lorusso, D.
  3. Gennigens, C.
  4. González-Martín, A.
  5. Randall, L.
  6. Cibula, D.
  7. Lund, B.
  8. Woelber, L.
  9. Pignata, S.
  10. Forget, F.
  11. Redondo, A.
  12. Vindeløv, S.D.
  13. Chen, M.
  14. Harris, J.R.
  15. Smith, M.
  16. Nicacio, L.V.
  17. Teng, M.S.L.
  18. Laenen, A.
  19. Rangwala, R.
  20. Manso, L.
  21. Mirza, M.
  22. Monk, B.J.
  23. Vergote, I.
Aldizkaria:
The Lancet. Oncology

ISSN: 1474-5488

Argitalpen urtea: 2021

Alea: 22

Zenbakia: 5

Orrialdeak: 609-619

Mota: Artikulua

DOI: 10.1016/S1470-2045(21)00056-5 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak